Phosphorylation and Alternative Pre-mRNA Splicing Converge To Regulate Myocyte Enhancer Factor 2C Activity

REFERENCES

• Ausubel, F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., and Struhl K.. 1998. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
   Google Scholar
• Bader, D., Masaki T., and Fischman D. A.. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763–770.
   PubMed Web of Science ®Google Scholar
• Bergstrom, D. A., Penn B. H., Strand A., Perry R. L., Rudnicki M. A., and Tapscott S. J.. 2002. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9:587–600.
   PubMed Web of Science ®Google Scholar
• Black, B. L., Lu J., and Olson E. N.. 1997. The MEF2A 3′ untranslated region functions as a cis-acting translational repressor. Mol. Cell. Biol. 17:2756–2763.
   PubMedGoogle Scholar
• Black, B. L., and Olson E. N.. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167–196.
   PubMed Web of Science ®Google Scholar
• Black, D. L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291–336.
   PubMed Web of Science ®Google Scholar
• Breitbart, R. E., Liang C. S., Smoot L. B., Laheru D. A., Mahdavi V., and Nadal-Ginard B.. 1993. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development 118:1095–1106.
   PubMed Web of Science ®Google Scholar
• Davies, S. P., Reddy H., Caivano M., and Cohen P.. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95–105.
   PubMed Web of Science ®Google Scholar
• De Angelis, L., Borghi S., Melchionna R., Berghella L., Baccarani-Contri M., Parise F., Ferrari S., and Cossu G.. 1998. Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. Proc. Natl. Acad. Sci. USA 95:12358–12363.
   PubMedGoogle Scholar
• Dhavan, R., and Tsai L.-H.. 2001. A decade of cdk5. Nat. Rev. Mol. Cell Biol. 2:7879–7891.
   Google Scholar
• Dodou, E., Sparrow D. B., Mohun T., and Treisman R.. 1995. MEF2 proteins, including MEF2A, are expressed in both muscle and non-muscle cells. Nucleic Acids Res. 23:4267–4274.
   PubMedGoogle Scholar
• Edmondson, D. G., Lyons G. E., Martin J. F., and Olson E. N.. 1994. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120:1251–1263.
   PubMed Web of Science ®Google Scholar
• Gong, X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., Blair L. A. C., Marshall J., and Mao Z.. 2003. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38:33–46.
   PubMed Web of Science ®Google Scholar
• Gunthorpe, D., Beatty K. E., and Taylor M. V.. 1999. Different levels, but not different isoforms, of the Drosophila transcription factor DMEF2 affect distinct aspects of muscle differentiation. Dev. Biol. 215:130–145.
   PubMedGoogle Scholar
• Han, J., Jiang Y., Li Z., Kravchenko V. V., and Ulevitch R. J.. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296–299.
   PubMed Web of Science ®Google Scholar
• Han, T. H., and Prywes R.. 1995. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15:2907–2915.
   PubMedGoogle Scholar
• Janson, C. G., Chen Y., Li Y., and Leifer D.. 2001. Functional regulatory regions of human transcription factor MEF2C. Mol. Brain Res. 97:70–82.
   PubMedGoogle Scholar
• Kato, Y., Zhao M., Morikawa A., Sugiyama T., Chakravortty D., Koide N., Yoshida T., Tapping R. I., Yang Y., Yokochi T., and Lee J. D.. 2000. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J. Biol. Chem. 275:18534–18540.
   PubMedGoogle Scholar
• Lazaro, J. B., Bailey P. J., and Lassar A. B.. 2002. Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev. 16:1792–1805.
   PubMedGoogle Scholar
• Lazaro, J. B., Kitzmann M., Poul M. A., Vandromme M., Lamb N. J. C., and Fernandez A.. 1997. Cyclin dependent kinase 5, cdk5, a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110:1251–1260.
   PubMed Web of Science ®Google Scholar
• Lee, Y., Nadal-Ginard B., Mahdavi V., and Izumo S.. 1997. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene. Mol. Cell. Biol. 17:2745–2755.
   PubMedGoogle Scholar
• Lin, J., Wu H., Tarr P. T., Zhang C. Y., Wu Z., Boss O., Michael L. F., Puigserver P., Isotani E., Olson E. N., Lowell B. B., Bassel-Duby R., and Spiegelman B. M.. 2002. Transcriptional co-activator PGC-1alpha drives the formation of slow-twitch muscle fibres. Nature 418:797–801.
   PubMed Web of Science ®Google Scholar
• Lin, Q., Lu J., Yanagisawa H., Webb R., Lyons G. E., Richardson J. A., and Olson E. N.. 1998. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125:4565–4574.
   PubMedGoogle Scholar
• Lin, Q., Schwarz J., Bucana C., and Olson E. N.. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404–1407.
   PubMed Web of Science ®Google Scholar
• Liu, S., Liu P., Borras A., Chatila T., and Speck S. H.. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16:143–153.
   PubMedGoogle Scholar
• Mao, Z., Bonni A., Xia F., Nadal-Vicens M., and Greenberg M. E.. 1999. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785–790.
   PubMed Web of Science ®Google Scholar
• Martin, J. F., Miano J. M., Hustad C. M., Copeland N. G., Jenkins N. A., and Olson E. N.. 1994. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14:1647–1656.
   PubMed Web of Science ®Google Scholar
• Martin, J. F., Schwarz J. J., and Olson E. N.. 1993. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. USA 90:5282–5286.
   PubMed Web of Science ®Google Scholar
• McDermott, J. C., Cardoso M. C., Yu Y. T., Andres V., Leifer D., Krainc D., Lipton S. A., and Nadal-Ginard B.. 1993. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell. Biol. 13:2564–2577.
   PubMed Web of Science ®Google Scholar
• McKinsey, T. A., Zhang C. L., Lu J., and Olson E. N.. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106–111.
   PubMed Web of Science ®Google Scholar
• McKinsey, T. A., Zhang C. L., and Olson E. N.. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11:497–504.
   PubMed Web of Science ®Google Scholar
• McKinsey, T. A., Zhang C. L., and Olson E. N.. 2002. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27:40–47.
   PubMed Web of Science ®Google Scholar
• Miska, E. A., Karlsson C., Langley E., Nielsen S. J., Pines J., and Kouzarides T.. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099–5107.
   PubMed Web of Science ®Google Scholar
• Molkentin, J. D., Black B. L., Martin J. F., and Olson E. N.. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125–1136.
   PubMedGoogle Scholar
• Molkentin, J. D., Black B. L., Martin J. F., and Olson E. N.. 1996. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell. Biol. 16:2627–2636.
   PubMedGoogle Scholar
• Mora, S., and Pessin J. E.. 2000. The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter. J. Biol. Chem. 275:16323–16328.
   PubMedGoogle Scholar
• Naya, F. J., Black B. L., Wu H., Bassel-Duby R., Richardson J. A., Hill J. A., and Olson E. N.. 2002. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 8:1303–1309.
   PubMed Web of Science ®Google Scholar
• Naya, F. S., and Olson E.. 1999. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11:683–688.
   PubMed Web of Science ®Google Scholar
• Okamoto, S., Krainc D., Sherman K., and Lipton S. A.. 2000. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl. Acad. Sci. USA 97:7561–7566.
   PubMed Web of Science ®Google Scholar
• Okamoto, S., Li Z., Ju C., Scholzke M. N., Mathews E., Cui J., Salvesen G. S., Bossy-Wetzel E., and Lipton S. A.. 2002. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 99:3974–3979.
   PubMedGoogle Scholar
• Ornatsky, O. I., and McDermott J. C.. 1996. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells. J. Biol. Chem. 271:24927–24933.
   PubMedGoogle Scholar
• Pollock, R., and Treisman R.. 1991. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 5:2327–2341.
   PubMed Web of Science ®Google Scholar
• Raingeaud, J., Whitmarsh A. J., Barrett T., Derijard B., and Davis R. J.. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247–1255.
   PubMed Web of Science ®Google Scholar
• Ridgeway, A. G., Wilton S., and Skerjanc I. S.. 2000. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. J. Biol. Chem. 275:41–46.
   PubMedGoogle Scholar
• Sartorelli, V., Huang J., Hamamori Y., and Kedes L.. 1997. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010–1026.
   PubMed Web of Science ®Google Scholar
• Suzuki, E., Lowry J., Sonoda G., Testa J. R., and Walsh K.. 1996. Structures and chromosome locations of the human MEF2A gene and a pseudogene MEF2AP. Cytogenet. Cell Genet. 73:244–249.
   PubMedGoogle Scholar
• Wang, D. Z., Valdez M. R., McAnally J., Richardson J., and Olson E. N.. 2001. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development 128:4623–4633.
   PubMed Web of Science ®Google Scholar
• Wu, H., Naya F. J., McKinsey T. A., Mercer B., Shelton J. M., Chin E. R., Simard A. R., Michel R. N., Bassel-Duby R., Olson E. N., and Williams R. S.. 2000. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J. 19:1963–1973.
   PubMed Web of Science ®Google Scholar
• Yang, S. H., Galanis A., and Sharrocks A. D.. 1999. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol. Cell. Biol. 19:4028–4038.
   PubMedGoogle Scholar
• Youn, H. D., Chatila T. A., and Liu J. O.. 2000. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19:4323–4331.
   PubMed Web of Science ®Google Scholar
• Yu, G. S., Lu Y. C., and Gulick T.. 1998. Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase IB gene promoters by fatty acid enzyme substrate. J. Biol. Chem. 273:32901–32909.
   PubMed Web of Science ®Google Scholar
• Yu, Y. T., Breitbart R. E., Smoot L. B., Lee Y., Mahdavi V., and Nadal-Ginard B.. 1992. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6:1783–1798.
   PubMed Web of Science ®Google Scholar
• Zhao, M., New L., Kravchenko V. V., Kato Y., Gram H., di Padova F., Olson E. N., Ulevitch R. J., and Han J.. 1999. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19:21–30.
   PubMedGoogle Scholar